untitled

Similar documents
MACSサイトカイン・グロースファクター価格表

Cytokines and Growth Factors 価格 HumanKine Activin A Re HEK293 ANGPTL5 Re HEK293 BAFF (TNFSF13B, BLys) 5 µg ,500 19, µg

サイトカイ50 ンLD78 β /CCL3L コード No. 希望納入価格 ( 円 ) IL-13 Variant IL IL-17F IL IL IL-22

< A F BF8A69955C8DEC90AC8D5291CC506C CB3967B292E786C7378>

LEGENDplex の特長 LEGENDplex は 一つのサンプルから多の可溶性タンパクを同時に定量できるフローサイトメーター用ビーズアッセイキットです 最大 13 まで同時測定が可能 Pre-defined Panel Mix & Match からキットを選べます 1 Pre-defined

PrmryCellCltrガイド_0620.indd

細胞培養・刺激に最適化された製品群

MACSスターティングキットの選択方法

セルシグナリング / リンタンパク質検出 印の項目が測定可能です MAPmates パネル Multi-pathway パネル Akt/PKB Akt/PKB ATF2 BAD Active Caspase 3 (Ser473) (Thr308) (Thr69/71) (Ser112) Erk/MA

<8DD AA97A3834C B BF8A69838A C8EA E786C7378>

PG1748-PJT2572-COL04214-D1D-ProcartaPlex-Bro-Correction-GlobalJ-1020.indd

Simple your Western. It s time. Meet the ProteinSimple product family Simple Western Simple Plex Biologics Toll-free: (888) Tel: (408)


好中球とPTX3

32P2018GIBCO価格表.indd

ページ製品名サイズ製品番号価格 5 FLoid Cell Imaging Station ,980,000 5 FLoid Printer, paper, cartridge & ink ,000 5 Ink and paper for FLoid pr

免疫学研究のための製品群

ÿþ

第14〜15回 T細胞を介する免疫系.pptx

ÿþ

メディカルスタッフのための白血病診療ハンドブック

Ł\”ƒ-2005

第90回日本感染症学会学術講演会抄録(I)


ALDEFLUOR® 造血幹細胞/造血前駆細胞の新しい同定試薬

BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mouse IgG , ,000 BE0005 TS-1/ InVivoMab anti-human LFA-1α (CD11a) mous

H26分子遺伝-20(サイトカイン).ppt

感度とダイナミックレンジは ELIS と同等 サンプルをマルチプレックスで測定したいとき 気になるのは精度 感度 そしてダイナミックレンジです ProcartaPlex ssays は厳密な ELIS の基準にあわせて最適化されています したがって ProcartaPlex ssays で多項目を測

CAR-T実施

Welcome to a ore Colorful World BD BD Horizon Brilliant Violet x 1, Lymph x 1, CD3+ CD8 PerCP-Cy5-5-A CD4+ 5 1

抄録/抄録1    (1)V

日本内科学会雑誌第98巻第4号

日本内科学会雑誌第97巻第7号

高感度 簡易 迅速ハイスループットマルチプレックスサイトカイン測定試薬 ProcartaPlex Assays 毒劇物非該当 pg/ml のサイトカインを測定可能 最大 65 項目のサイトカインを同時測定 Simplex の各項目のキットを組み合わせてアッセイ可能 ProcartaPlex Assa

DynalTransplantDiagnostic.indd


2 A2B, 0/A2B IgM AF647 0 T ,000 C3/AFP IgG Annexin V AF488 0 T ,000 PE 0 T ,000 APC 2 T ,000 FITC 2 T ,000 PE 2 T 60

第 14 回血管病理研究会 日時 : 平成 20 年 10 月 10 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ) CRP MPO-ANCA 125IU/l CT mpa

パーキンソン病治療ガイドライン2002

研修コーナー

Immunoassay_Brochure_1002.indd



9 : : : : : : : : : 00

MACS機器予算申請カタログ

A 1 血球の産生 崩壊とその調節 血球の個体発生 個体の発生過程で最初の造血は 胎生 25 日頃より胚外の卵黄囊の壁内で起こる この時期に産 生される赤血球は脱核せず グロビン遺伝子も成体型のものとは異なり この造血を一次造血と呼 ぶ 一次造血に続いて成体型の造血 二次造血 の起源となる真の造血幹

Z...QXD (Page 1)

190117_Quidel社カタログ改訂【初校】.indd

Gibco Gibco


日本医科大学医学会雑誌第7巻第2号

jcvp試験問題HP.indd

untitled

DiovNT

RN201602_cs5_0122.indd

日本内科学会雑誌第102巻第4号

H


1

論文の内容の要旨

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6


Immunology Sourcebook_CS indd

第86回日本感染症学会総会学術集会後抄録(I)

untitled

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN

1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e

放射線専門医認定試験(2009・20回)/HOHS‐05(基礎二次)

プログラム

BrdU Flow Kit


研究成果報告書

能書単頁9[1].5(2)

, 1. x 2 1 = (x 1)(x + 1) x 3 1 = (x 1)(x 2 + x + 1). a 2 b 2 = (a b)(a + b) a 3 b 3 = (a b)(a 2 + ab + b 2 ) 2 2, 2.. x a b b 2. b {( 2 a } b )2 1 =

プログラム

MacugenInsert01.ai

第124回日本医学会シンポジウム

日本歯科保存学会2011年度春季学術大会(134回)

研究計画書 地域における生活習慣が影響を与えると考えられる疾患の追跡研究 長崎大学大学院医歯薬学総合研究科 先進予防医学講座地域医療学分野 研究等責任者教授前田隆浩 作成年月日 : 平成 27 年 3 月 4 日 改訂年月日 : 平成 28 年 3 月 11 日 平成 28 年 10 月 13 日

ha 0 2,000 4,000 6,000 8,000 10,

研究成果報告書

PowerPoint プレゼンテーション

ROWCatPathology_J.book

jigp60-★WEB用★/ky494773452500058730

プログラム


x V x x V x, x V x = x + = x +(x+x )=(x +x)+x = +x = x x = x x = x =x =(+)x =x +x = x +x x = x ( )x = x =x =(+( ))x =x +( )x = x +( )x ( )x = x x x R

5 ex. neo^r ex. P. ips induced Pluripotent Stem cells 4 ES ex. ex. DNA


Untitled

qxd

2016.

第121回関東連合産科婦人科学会総会・学術集会 プログラム・抄録


Microsoft PowerPoint - 04 池袋 一典 教授

総合カタログ ー マルチプレックスサスペンションアレイテクノロジー

untitled

カズノコの栄養機能性.ppt

PowerPoint プレゼンテーション

_4th2..

Transcription:

MACS Cytokines product list 2015-467 MACS Miltenyi Biotec Nature ES/iPS MACS Research grade Premium grade ex vivo GMP grade MACS WEB www.miltenyibiotec.co.jp/cedp

HUMAN Cytokines and Growth Factors 130-097-608 HumanKine Re HEK293 5 μg 25,000 130-097-610 Activin A 50 μg 124,100 130-097-611 200 μg 477,500 130-096-125 ANGPTL5 Re HEK293 5 μg 27,000 130-096-126 25 μg 103,100 130-093-806 BAFF 130-093-807 (TNFSF13B, BLys) 130-093-809 BD-2 Re E. coli 130-093-810 BD-3 130-094-615 130-096-285 BDNF Re E. coli 2 μg 11,000 130-093-811 130-096-286 100 μg 165,200 130-103-435 1000 μg 130-093-814 BMP-2 Re E. coli 2 μg 11,000 130-093-812 130-094-616 100 μg 165,200 130-098-786 HumanKine Re HEK293 10 μg 32,000 130-098-787 BMP-4 50 μg 124,100 130-098-788 200 μg 435,400 130-093-818 BMP-7 Re CHO 130-103-436 100 μg 249,200 130-096-711 CD40-Ligand Pr E. coli 10 μg 25,000 130-096-712 soluble (TRAP, CD154, TNFSF5) 25 μg 37,000 130-096-713 100 μg 103,100 130-096-714 500 μg 130-098-775 CD40-Ligand Pr E. coli 100 μg 165,200 130-098-776 Multimer kit 1 500 μg 130-105-768 CD137-Ligand 130-105-767 (4-1BB-Ligand) 130-096-337 CNTF 130-096-336 130-103-443 DKK-1 Re HEK293 2 μg 11,000 130-103-444 130-103-445 100 μg 165,200 130-093-825 EGF Re E. coli 100 μg 11,000 130-097-749 Pr E. coli 100 μg 14,000 130-097-750 500 μg 130-097-751 1000 μg 130-093-829 EG-VEGF Re E. coli (Prokineticin 1) 130-093-833 Exodus-2 130-094-618 (CCL21, SLC) 130-093-835 FGF-1 130-095-789 (acidic FGF, afgf, HBGF-1) 25 μg 22,000 130-095-790 Pr E. coli 10 μg 14,000 130-095-763 25 μg 28,000 130-095-761 100 μg 50,100 130-095-756 1000 μg 130-093-837 (basic FGF, bfgf,hbgf-2) 130-093-838 50 μg 25,000 130-093-839 Pr E. coli 10 μg 14,000 130-093-840 50 μg 37,000 130-093-564 100 μg 50,100 130-093-841 200 μg 82,100 130-093-842 1000 μg 130-093-843 2000 μg 130-104-925 IS Re E. coli 10 μg 14,000 (improved sequence) (basic FGF, bfgf) 130-104-921 50 μg 37,000 130-104-918 Pr E. coli 10 μg 20,000 130-104-924 50 μg 52,100 130-104-922 200 μg 103,100 130-104-923 1000 μg 130-093-845 FGF-4 (HBGF-4) Re E. coli 25 μg 37,000 130-093-849 FGF-7 (KGF, HBGF-7) 130-097-175 25 μg 57,100 130-097-173 Pr E. coli 130-097-178 25 μg 72,100 130-097-176 100 μg 165,200 130-095-731 FGF-8b Re E. coli 10 μg 20,000 130-095-733 25 μg 30,000 130-095-737 Pr E. coli 10 μg 25,000 130-095-738 25 μg 37,000 130-095-740 100 μg 103,100 130-095-741 1000 μg 130-103-446 FGF-9 130-103-447 50 μg 61,100 130-093-850 FGF-10 (KGF-2) Re E. coli 25 μg 37,000 130-105-770 FGF-19 130-105-769 25 μg 37,000 130-105-772 1 130-105-771 25 μg 37,000 130-093-854 Flt3-Ligand 130-096-474 25 μg 57,100 130-096-476 Pr E. coli 130-096-477 25 μg 72,100 130-096-479 100 μg 124,100 130-096-480 1000 μg 130-093-857 Galectin-1 Re E. coli 50 μg 37,000 130-093-858 Galectin-3 Re E. coli 50 μg 37,000 130-096-345 G-CSF 130-096-346 25 μg 57,100 130-093-860 Pr E. coli 130-096-347 25 μg 72,100 130-093-861 100 μg 165,200 130-094-265 1000 μg 130-105-776 GDF-11 130-105-775 130-096-290 GDNF Re E. coli 2 μg 11,000 130-096-291 130-098-449 100 μg 165,200 2

130-093-862 Re E. coli 10 μg 20,000 (CSF2) 130-095-372 50 μg 46,000 130-093-864 Pr E. coli 10 μg 25,000 130-093-865 50 μg 57,100 130-093-866 100 μg 103,100 130-093-867 500 μg 130-093-868 1000 μg 130-094-620 GRO-α (CXCL1, MGSAα) 130-093-869 25 μg 37,000 130-093-870 GRO-β (CXCL2, Re E. coli 2 μg 11,000 MGSAβ, MIP-2α) 130-094-621 130-093-871 HGF 2 Re Insect 5 μg 20,000 130-093-872 (HPTA, SF) 25 μg 72,100 130-103-437 100 μg 165,200 130-093-873 IFN-α2a Re E. coli 20 μg 11,000 130-093-874 100 μg 37,000 130-093-875 IFN-α2b Re E. coli 20 μg 11,000 130-093-876 100 μg 37,000 130-107-889 IFN-β1a Re CHO 5 μg 11,000 130-107-888 130-093-878 IFN-β1b Re E. coli 2 μg 11,000 130-094-619 130-096-872 IFN-γ1b (IFN-γ) 130-096-873 25 μg 16,000 130-096-481 Pr E. coli 10 μg 14,000 130-096-482 25 μg 20,000 130-096-484 100 μg 41,000 130-096-486 1000 μg 130-093-885 IGF-1 Re E. coli 50 μg 28,000 (IGF-I) 130-093-886 100 μg 37,000 130-093-887 1000 μg 130-093-888 IGF-2 (IGF-II) 130-093-889 50 μg 37,000 130-093-890 1000 μg 130-093-893 IL-1α Re E. coli 2 μg 11,000 130-093-894 130-093-895 IL-1β (IL1F2) 130-095-374 25 μg 57,100 130-093-897 Pr E. coli 130-093-563 25 μg 72,100 130-093-898 100 μg 124,100 130-093-899 1000 μg 130-096-142 IL-1ra Re E. coli 20 μg 11,000 130-097-742 IL-2 IS (improved sequence) 130-097-743 50 μg 30,000 130-097-744 Pr E. coli 10 μg 14,000 130-097-745 50 μg 37,000 130-097-746 200 μg 61,100 130-097-748 1000 μg 130-093-908 Re E. coli 10 μg 26,000 130-093-909 25 μg 41,000 130-094-193 4 x 25μg 103,100 130-095-071 Pr E. coli 10 μg 32,000 130-095-070 25 μg 52,100 130-095-069 100 μg 103,100 130-095-068 1000 μg 130-093-915 Re E. coli 5 μg 13,000 130-095-373 10 μg 20,000 130-093-917 25 μg 41,000 130-094-117 100 μg 82,100 130-093-919 Pr E. coli 5 μg 17,000 130-093-920 10 μg 25,000 130-093-921 25 μg 52,100 130-093-922 100 μg 103,100 130-093-924 1000 μg 130-093-926 IL-5 Re E. coli 2 μg 11,000 130-093-927 130-095-365 IL-6 Re E. coli 10 μg 26,000 130-093-929 25 μg 41,000 130-095-352 Pr E. coli 10 μg 32,000 130-093-931 25 μg 52,100 130-093-932 100 μg 103,100 130-093-933 500 μg 130-093-934 1000 μg 130-093-937 IL-7 130-095-367 25 μg 57,100 130-095-361 Pr E. coli 130-095-362 25 μg 72,100 130-095-363 100 μg 165,200 130-095-364 1000 μg 130-093-942 IL-8 (72 aa) (CXCL8) 130-093-943 25 μg 37,000 130-093-944 IL-8 (77 aa) (CXCL8) Re E. coli 25 μg 37,000 130-093-945 IL-9 Re E. coli 2 μg 11,000 130-093-946 130-103-438 100 μg 165,200 130-093-947 IL-10 Re E. coli 2 μg 11,000 130-093-948 130-098-448 100 μg 165,200 130-094-623 IL-11 Re E. coli 2 μg 11,000 130-093-950 130-103-439 100 μg 165,200 130-096-704 IL-12 Pr HEK293 5 μg 25,000 130-096-705 25 μg 78,100 130-096-798 100 μg 249,200 130-093-953 IL-13 Re E. coli 2 μg 11,000 130-093-954 130-103-440 100 μg 165,200 Re : Research Pr : Premium 03-5646-8910( ) macs@miltenyibiotec.jp 3

HUMAN Cytokines and Growth Factors 130-093-955 IL-15 130-095-760 25 μg 57,100 130-095-762 Pr E. coli 130-095-764 25 μg 72,100 130-095-765 100 μg 124,100 130-095-766 1000 μg 130-104-919 IL-15Rα sushi 130-104-920 25 μg 22,000 130-104-912 Pr E. coli 10 μg 14,000 130-104-916 25 μg 28,000 130-104-914 100 μg 61,100 130-093-958 IL-17A 130-093-959 25 μg 37,000 130-094-625 100 μg 124,100 130-103-452 IL-17F 130-103-453 25 μg 37,000 130-094-626 IL-19 Re E. coli 2 μg 11,000 130-093-960 130-094-563 IL-21 130-095-767 25 μg 57,100 130-095-768 Pr E. coli 130-095-769 25 μg 72,100 130-095-784 100 μg 165,200 130-096-294 IL-22 Re E. coli 2 μg 11,000 130-096-295 130-096-297 100 μg 165,200 130-095-757 IL-23 Re HEK293 5 μg 27,000 130-095-758 25 μg 103,100 130-095-759 100 μg 332,300 130-105-779 IL-24 Re CHO 5 μg 11,000 130-105-777 130-103-460 3 Re E. coli 2 μg 11,000 130-103-461 130-105-781 4 Re HEK293 2 μg 11,000 130-105-780 130-108-159 LIF 130-108-157 25 μg 37,000 130-108-156 100 μg 138,100 130-108-155 1000 μg 130-093-961 MCP-1 130-093-962 (CCL2, MCAF) 130-093-963 M-CSF 130-096-491 (CSF1) 25 μg 57,100 130-096-485 Pr E. coli 130-096-489 25 μg 72,100 130-096-492 100 μg 124,100 130-096-493 1000 μg 130-093-966 MIP-3α Re E. coli (CCL20, Exodus-1) 130-105-744 MIP-3β 130-105-743 (CCL19, ELC, Exodus-3) 25 μg 37,000 130-093-969 100 μg 124,100 130-093-971 NGF-β Re CHO 5 μg 20,000 130-093-972 (β-ngf) 20 μg 41,000 130-103-441 100 μg 103,100 130-103-454 Noggin Re HEK293 5 μg 11,000 130-103-455 130-103-456 100 μg 124,100 130-096-287 NT-3 Re E. coli 2 μg 11,000 130-093-973 (NTF-3, HDNF) 130-096-288 100 μg 165,200 130-096-289 NT-4 Re E. coli 2 μg 11,000 130-093-974 (NTF-4) 130-093-975 Oncostatin M (OSM) Re E. coli 2 μg 11,000 130-093-976 130-098-223 100 μg 165,200 130-099-231 1000 μg 130-094-119 OPG Re Yeast 50 μg 37,000 (TNFRSF11B, TR1) 130-093-977 PDGF-AA Re E. coli 2 μg 11,000 130-093-978 130-094-629 PDGF-AB Re E. coli 2 μg 11,000 130-093-979 130-103-442 100 μg 124,100 130-108-165 PDGF-BB IS Re Yeast 10 μg 26,000 130-108-164 (improved sequence) 25 μg 41,000 130-108-163 Pr Yeast 10 μg 32,000 130-108-162 25 μg 52,100 130-108-161 100 μg 103,100 130-108-160 1000 μg 130-093-985 Prolactin Re E. coli 50 μg 37,000 (Mammotropin) 130-093-987 RANK-Ligand Re E. coli 2 μg 11,000 130-093-988 soluble (TNFSF11, TRANCE, ODF) 130-094-631 100 μg 165,200 130-093-989 RANTES 130-094-632 (CCL5) 130-105-799 R-Spondin -1 Re CHO 5 μg 11,000 130-105-800 (Rspo-1, F-spondin) 130-105-803 R-Spondin -2 Re CHO 5 μg 11,000 130-105-802 (Rspo-2) 130-105-801 R-Spondin -3 Re CHO 5 μg 11,000 130-105-804 (Rspo-3) 130-093-991 SCF Re E. coli 10 μg 26,000 130-096-692 (c-kit Ligand, steel factor, MGF) 25 μg 41,000 130-096-693 Pr E. coli 10 μg 32,000 130-096-694 25 μg 52,100 130-096-695 100 μg 103,100 130-096-696 1000 μg 130-093-996 SDF-1α Re E. coli 10 μg 32,000 130-096-137 (CXCL12) 25 μg 52,100 130-093-997 100 μg 103,100 130-093-998 1000 μg 130-095-717 SHH (C24II) Re E. coli 10 μg 26,000 130-095-718 25 μg 41,000 130-095-721 Pr E. coli 10 μg 32,000 130-095-723 25 μg 52,100 130-095-727 100 μg 103,100 130-095-730 1000 μg 130-093-999 TARC (CCL17) Re E. coli 4

MOUSE Cytokines and Growth Factors 130-095-067 TGF-β1 Pr HEK293 5 μg 50,100 130-095-066 25 μg 110,100 130-094-007 TGF-β3 3 Re E. coli 5 μg 27,000 130-094-008 20 μg 103,100 130-094-015 TNF-α Re Yeast 10 μg 11,000 130-094-017 (TNFSF2) 50 μg 30,000 130-094-018 100 μg 49,000 130-094-019 750 μg 130-094-020 1000 μg 130-094-022 Pr Yeast 10 μg 14,000 130-094-023 50 μg 37,000 130-094-024 100 μg 61,100 130-094-562 1000 μg 130-094-014 Pr E. coli 10 μg 14,000 130-094-011 TPO 130-094-013 (MDGF) 100 μg 145,100 130-094-025 TRAIL 130-094-026 (Apo2 Ligand, TNFSF10) 50 μg 37,000 130-106-271 TSLP Re E. coli 2 μg 11,000 130-106-270 130-094-029 VEGF (121 aa) 2 Re Insect 5 μg 41,000 130-094-030 100 μg 165,200 130-094-031 VEGF (165 aa) 2 Re Insect 5 μg 41,000 130-094-033 20 μg 73,100 130-094-034 100 μg 239,200 130-094-035 500 μg 1 Cross link 2-8 C 2 3-20 C 130-094-036 EGF Re E. coli 100 μg 11,000 130-094-037 500 μg 130-105-787 (basic FGF, bfgf, HBGF-2) 130-105-786 50 μg 37,000 130-096-100 FGF-8b Re E. coli 10 μg 20,000 130-096-101 25 μg 30,000 130-096-102 Pr E. coli 10 μg 25,000 130-096-103 25 μg 37,000 130-096-104 100 μg 103,100 130-096-105 1000 μg 130-094-038 Flt3-Ligand Re E. coli 130-097-372 100 μg 124,100 130-094-039 G-CSF Re E. coli 2 μg 11,000 130-094-040 130-094-041 100 μg 165,200 130-094-043 Re E. coli 10 μg 26,000 (CSF2) 130-095-746 25 μg 41,000 130-095-742 Pr E. coli 10 μg 32,000 130-095-793 25 μg 52,100 130-095-739 100 μg 103,100 130-095-735 1000 μg 130-094-045 Gro-α/KC (CXCL1) 130-094-046 130-093-131 IFN-α 1 Re HEK293 200 μl 61,100 130-093-130 1 ml 130-094-047 IFN-γ Re E. coli 20 μg 11,000 130-094-048 100 μg 37,000 130-094-049 1000 μg 130-094-050 IL-1α Re E. coli 2 μg 11,000 130-094-051 130-094-053 IL-1β (IL1F2) 130-101-680 25 μg 57,100 130-101-681 Pr E. coli 130-101-682 25 μg 72,100 130-101-683 100 μg 165,200 130-101-684 1000 μg 130-094-054 IL-2 130-094-055 130-098-221 100 μg 103,100 130-096-687 IS (improved sequence) 130-096-688 25 μg 57,100 130-099-508 Pr E. coli 130-099-509 25 μg 72,100 130-099-510 100 μg 124,100 130-099-511 1000 μg 130-094-061 Re E. coli 10 μg 26,000 130-097-757 25 μg 41,000 130-097-761 Pr E. coli 10 μg 32,000 130-097-760 25 μg 52,100 130-097-759 100 μg 103,100 130-097-758 1000 μg 130-105-789 IL-5 130-105-788 25 μg 37,000 Re : Research Pr : Premium 03-5646-8910( ) macs@miltenyibiotec.jp 5

MOUSE Cytokines and Growth Factors 130-094-065 IL-6 130-096-683 25 μg 57,100 130-096-682 Pr E. coli 130-096-684 25 μg 72,100 130-096-685 100 μg 124,100 130-096-686 1000 μg 130-094-636 IL-7 Re E. coli 2 μg 11,000 130-094-066 130-098-222 100 μg 165,200 130-094-067 IL-10 Re E. coli 2 μg 11,000 130-094-068 130-096-707 IL-12 Re HEK293 5 μg 25,000 130-096-708 25 μg 78,100 130-096-795 100 μg 249,200 130-094-639 IL-13 Re E. coli 2 μg 11,000 130-094-070 130-094-071 IL-15 Re E. coli 2 μg 11,000 130-094-072 130-094-640 100 μg 165,200 130-103-448 IL-17A 130-103-449 25 μg 37,000 130-103-450 IL-17F 130-103-451 25 μg 37,000 130-096-298 IL-22 Re E. coli 2 μg 11,000 130-096-283 130-096-676 IL-23 Re HEK293 5 μg 27,000 130-096-677 25 μg 103,100 130-094-073 IP-10 (CXCL10) 130-094-641 25 μg 37,000 130-095-772 LIF 130-095-775 25 μg 57,100 130-095-777 Pr E. coli 130-095-778 25 μg 72,100 130-095-779 100 μg 124,100 130-099-895 10x100 μg 130-094-129 M-CSF (CSF1) 130-101-706 25 μg 57,100 130-101-703 Pr E. coli 130-101-700 25 μg 72,100 130-101-704 100 μg 124,100 130-101-705 1000 μg 130-094-644 MIG (CXCL9) 130-094-128 130-094-120 MIP-3β (CCL19, ELC, Exodus-3) 130-094-074 130-094-075 100 μg 124,100 130-103-457 Noggin 130-103-458 20 μg 30,000 130-103-459 100 μg 124,100 130-094-645 RANK-Ligand Re E. coli 2 μg 11,000 130-094-076 soluble (TNFSF11) 130-094-646 100 μg 165,200 130-094-077 RANTES (CCL5) Re E. coli 130-094-079 SCF Re E. coli 10 μg 26,000 130-101-741 (c-kit Ligand, steel factor, MGF) 25 μg 41,000 130-101-693 Pr E. coli 10 μg 32,000 130-101-694 25 μg 52,100 130-101-697 100 μg 103,100 130-101-698 1000 μg 130-094-081 SDF-1α Re E. coli 2 μg 11,000 130-094-647 (CXCL12) 130-101-688 TNF-α Re E. coli 10 μg 26,000 130-101-687 (TNFSF2) 25 μg 41,000 130-101-689 Pr E. coli 10 μg 32,000 130-101-690 25 μg 52,100 130-101-691 100 μg 103,100 130-101-692 1000 μg 130-094-082 TPO Re E. coli 2 μg 11,000 130-094-083 (MDGF) 130-096-301 100 μg 165,200 130-094-086 VEGF Re Insect 5 μg 31,000 130-094-087 (164 aa) 2 20 μg 73,100 1-20 C 2 RAT Cytokines and Growth Factors 130-094-089 IFN-γ Re E. coli 100 μg 37,000 130-094-121 IL-2 130-094-090 130-094-091 Re E. coli 2 μg 11,000 130-094-122 130-094-092 VEGF-C 1 Re Insect 130-094-093 VEGF-C (C152S) 1 Re Insect 5 μg 31,000 1 6 Re : Research Pr : Premium 03-5646-8910( ) macs@miltenyibiotec.jp

MACS NeuroBrew-21 & NeuroMedium B27MACS NeuroBrew-21 MACS Neuro Medium CNS PNS MBP MACS Neuro Medium + MACS NeuroBrew-21+ L-glutamine PDGF-AA, PSA-NCAM MicroBeads MACS NeuroBrew-21 MACS Neuro Medium 7 GAD67 130-093-570 MACS Neuro Medium (,, ) 500 ml 6,800 130-093-566 MACS NeuroBrew-21 (50x) 10 ml 18,000 130-097-263 MACS NeuroBrew-21 (50x, Vitamin A) 10 ml 18,000 2-8 C GMP GMP/GCTP TR translational research (ex vivo) GMP HUMAN GMP HUMAN 170-076-406 EGF GMP E. coli 100 μg 110,000 170-076-407 500 μg 340,000 170-076-107 GMP E. coli 25 μg 80,000 (basicfgf, bfgf) 170-076-125 500 μg 400,000 170-076-132 Flt3-Ligand GMP E. coli 100 μg 340,000 170-076-112 GMP E. coli 25 μg 80,000 170-076-136 250 μg 320,000 170-076-102 IL-1β GMP E. coli 25 μg 110,000 170-076-113 IL-2 GMP E. coli 20 μg 38,000 170-076-146 100 μg 95,000 500 μg coming soon 170-076-110 GMP E. coli 25 μg 80,000 170-076-101 GMP E. coli 25 μg 110,000 170-076-135 250 μg 320,000 170-076-104 IL-6 GMP E. coli 10 μg 50,000 170-076-111 IL-7 GMP E. coli 25 μg 110,000 170-076-114 IL-15 GMP E. coli 25 μg 110,000 170-076-115 IL-21 GMP E. coli 25 μg 110,000 170-076-133 SCF GMP E. coli 100 μg 340,000 170-076-103 TNF-α GMP E. coli 25 μg 80,000 TPO GMP E. coli 50 μg coming soon GMP : GMP 7

MACS MACS TexMACS T T TregT HSA RPMI1640 + 10%FCS T GMPPR(phenol red) T TexMACS 2-8 C 130-097-196 TexMACS Medium, research grade 500 ml 12,000 170-076-309 TexMACS GMP medium 1 L 18,000 170-076-307 TexMACS GMP medium(pr) 1 L 18,000 170-076-306 TexMACS GMP medium(pr) 2 L 36,000 TexMACS GMP grade TexMACS reseach grade RPMI + 10% FCS 0 2 4 6 8 10 11 12 13 14 15 16 Expansion rate (x10 n ) CD3 + CD4 + CD8 + TexMACS Medium 10%FCS+RPMI T TexMACS Medium FCS RPMI CD4 + T CD8 + T CytoBox CytoBox Cytobox Mo-DC() Mo-DCs monocyte-derived dendritic Premium grade Cytobox Anti-IFN-γ-APC CytoBox Th1 Anti-IFN-γ-APC / Anti--PE Anti-T-bet-PE 130-100-842 CytoBox Mo-DC 1 406,400 CytoBox Th2 Cytobox Th( ) CD4 + T in vitro polarization Th1 Th2 Th17 TexMACS Medium T cell Activation/Expansion Kit Anti-IFN-γ-APC Anti--PE Anti-T-bet-PE Anti-GATA3-APC Cytobox Th( ) / 2-8 C / 130-107-761 CytoBox Th1 IL-12 IL-2 Anti- 130-107-760 CytoBox Th2 IL-2 Anti-IFN-γ 1 59,100 1 55,100 Anti-IFN-γ-APC CytoBox Th17 Anti-RORγ (t)-apc Anti-IL-17A-PE Anti-IL-17A-PE 130-107-758 CytoBox Th17 IL-6, TGF-β, IL-1β, IL-23 Anti-IFN-γ,, IL-2 1 179,200 CD4 + in vitro polarization TexMACS Medium, 10% FCS, T cell Activation/Expansion Kit (#130-093-627) CytoBox 5 Intracellular staining Th lineage 8

Helper T Naive CD4 T cell IL-2 Anti-CD3 Anti-CD28 IL-12 IL-18 IL-27 IFN-γ Anti- IL-6 1 IL-23 TSLP IL-25 Anti-IL-12 Anti-IFN-γ TGF-β1 Anti-IFN-γ TGF-β1 TGF-β1 IL-1β IL-6 IL-21 IL-23 Anti-IL-2 Anti- Anti-IFN-γ IL-6 IL-21 CXCL13 IL-6 TNF-α TH1 cell TH2 cell TH9 cell itreg cell TH17 cell Tfh cell TH22 cell CD4, CD94, CD119 (IFN-γ), CD183 (CXCR3), CD195 (CCR5), Tim-3 CD4, CD119 (IFN-γ), CD193 (CCR3), CD194 (CCR4), Tim-1 CD4, TCRα/β CD196 (CCR6) CD4, CD25, CD127 - CD4, CD161, CD194 (CCR4), CD196 (CCR6) CD4, TCRα/β, CD185 (CXCR5), CD197 (CCR7), CD69 CD4, CD194 (CCR4), CD196 (CCR6), CCR10 T-bet, STAT1, STAT4 GATA3, STAT6 IRF4, GATA3, STAT6 FoxP3, STAT5, Smad2 RORγt, STAT3 STAT3, Bcl6 BNC2, FOXO4 IL-2, IL-10, IFN-γ, TNF-α,, IL-5, IL-6, IL-10, IL-13 IL-9, IL-10 IL-10, TGF-β1, 5 IL-17A, IL-17F, IL-21, IL-22, IL-26 IL-6, IL-10, IL-12, IL-21 IL-13, IL-22, TNF-α Polarizing cytokines Surface marker profile Transcription factors Secreting cytokines Blocking or neutralizing antibodies Activating antibodies in vivo Azide-free in vitro in vivo (1mg~) MACSCustom@miltenyibiotec.jp 03-5646-9606 (9:00-17:00) 2-8 C 130-093-387 CD3 pure() 100 μg 35,000 130-093-375 CD28 pure() 100 μg 35,000 130-094-271 CD335 (NKp46) pure() 100 μg 45,000 130-094-865 Anti-iNKT pure () 100 μg 45,000 130-095-743 Anti-IFNγ pure () 500 μg 64,000 130-095-753 Anti- pure () 500 μg 64,000 130-095-755 Anti-IL-12 (p40/p70)pure () 500 μg 68,000 130-093-052 CD357 (GITR)pure () 500 μg 98,000 130-096-168 CD279 (PD-1) pure () 500 μg 68,000 WEB B cell Expansion Kit () B / 2-8 C B / 7 10 215 200 130-106-196 B cell Expansion Kit CD40-Ligand, Cross-Link StemMACS HSC Expansion Media XF 1 890,000 : 9

StemMACS TM mrna, StemMACS StemMACS ips-brew XF(xeno-free media) ES/iPS Feeder-Free Xeno-Free On-Feeder Feeder-Free StemMACS MSC Expansion Media Kit XF Xeno-Free MSCs ( ) StemMACS ips-brew XF 20 ips ( ) StemMACS mrna Reprogramming Kit ips StemMACS HSC Expansion Media XF Xeno-Free StemMACS HSC Expansion Cocktail StemMACS ips-brew XF ips NOD-Scid 8 3 StemMACS ips 130-104-368 StemMACS ips-brew XF () *1 500 ml + 5 ml 29,000 130-104-688 StemMACS Passaging Solution XF *2 100 ml 7,500 (MSCs) 130-104-182 StemMACS MSC Expansion Media Kit XF () *1 500 ml + 7 ml 59,000 130-100-473 StemMACS HSC Expansion Media XF ( ) 100 ml 20,000 (HSCs) 130-100-463 StemMACS HSC Expansion Media XF ( ) 500 ml 65,000 130-100-843 StemMACS HSC Expansion Cocktail () 1 100 ml 98,000 *12-8 C*2 : StemMACS small molecule CHIR99021 Wnt GSK3β PD0325901 MEK A83-01 TGF-β, Activin Nodal SB431542 TGF-β, Activin Nodal Dorsomorphin BMP AMP Purmorphamine IWP-2 β Wnt LDN-193189 BMP type I ALK2 ALK3 Thiazovivin Rho-associated kinase (ROCK) LY411575 Notchγ RG108 DNA methyltransferase (DNMT) StemMACS mrna & StemMACS mrna Reprogramming Kit Feeder-Free mrna Conditioned medium 2 StemMACS mrna Transfection Kit mrna StemMACS Repro-Brew XF mrna PPAR-gamma, C/EBP-beta Brn2, Lmx1a, Mash1, NeuroD1, NeuroG2, Nurr1, Myt1l Progerin-eGFP Nuclear egfp, egfp Flp Recombinase, Cre Recombinase Cas9 Nickase, Cas9 Nuclease 10

PSCs /, TGF-β1, Thiazovivin, Y27632 ips/es Activin A CHIR99021 Pluripotent stem cell (ESC/iPSC) FGFs, Noggin, SB431542, Dorsomorphin, LDN-193189 BMP-4 Ascorbic acid Definitive endoderm Keratinocyte Neural stem cell A83-01 Dorsomorphin Noggin Wnt3a FGF-4 FGF-10 Retinoid acid SB431542 Retinoid acid Noggin FGF-7 BMP-4 EGF VEGF Dorsomorphin SHH FGF-8b SHH CNTF SHH PDGF Retinoid acid EGF Anterior endoderm BMP-4 WNTs Hindgut endoderm R-Spondins EGF Noggin Hepatic progenitor HGF FGF-4 EGF Pancreatic progenitor Exendin-4 BMP-4 Nicotinamide Multipotent endodermal progenitor cell Neural Crest NGF BDNF GABA neuron Dopaminergic neuron Astrocyte Oligodendrocyte Cortical neuron Multipotent lung progenitor Intestinal tissue Hepatocyte β-islet cell Insulin, Transferrin, Selenium, Serum Peripheral neuron BMP-4, Activin-A,, CHIR99021 Insulin IBMX Dexamethasone Mesenchymal stem cell Dexamethasone TGF-β1 TGF-β3 Ascorbic acid SCF, TPO Flt3-L IL-6, G-CSF BMP-4, VEGF SCF, TPO, Flt3L Primitive streak mesoderm XAV939 KY02111 DKK-1 IWP-2 VEGF SB431542 Adipocyte Osteogenic cell Chondrocyte Hematopoietic stem cell Cardiomyocyte Endothelial cell SCF IL-7 SCF TPO, IL-6, G-CSF,, EPO Lymphoid progenitor Megakaryocyte erythrocyte progenitor Common myeloid progenitor SCF, IL-1β IL-6, IL-7 IL-11, IL-12 SCF IL-2 IL-12 SCF, IL-1β IL-2, IL-6 IL-7 TPO EPO M-CSF IL-10 TSLP IL-5 G-CSF SCF TGF-β1 B cell lineage TGF-β1, BAFF IL-2, IFN-γ, CD40L anti CD40 anti CD180 anti IgM/IgD NK cell lineage IL-2 IL-12 IL-15 IL-18 T cell lineage IL-2 IL-7 IL-15 CD137L anti CD3 anti CD28 Megakaryocyte lineage Erythroid lineage M-CSF RANK-L Monocytic lineage Flt3L M-CSF 4 Basophilic lineage IFN-γ Flt3L 4 Eosinophilic lineage Neutrophilic lineage Mast cell lineage Activated B cell Activated NK cell Osteoclast Macrophage TNF-α, IFN-γ, IL-1β IL-13 Dendritic cell IL-1β, TNF-α IL-6, IL-23 CD40L Plasma cell NK T cell γδ T cell CD4 naive T cell CD8 naive T cell Treg cell Mature macrophage Mature dendritic cell StemMACS MACS Activating antibodies 11

MACS Research grade 1 Research grade 0.1 ng/μg(1 EU/μg) 95% 1 WHO NIBSC 2 Carrier 2 Carrier-freetrehalose, mannitolstabilizer premium grade / 2 Mouse LIF (premium grade) ES WEB GMP gradeex vivo GMP ISO 9001:2000 MACS GMP USP( )<1043> ancillary materials www.miltenyibiotec.co.jp/cedp MACS Miltenyi Biotec GmbH Miltenyi Biotec 135-0041 16-10 NEX5F TEL 03-5646-8910FAX 03-5646-8911 www.miltenyibiotec.co.jp E-mail macs@miltenyibiotec.jp 03-5646-9606 0120-03-5645 03-5646-8566 AM9 00 PM5 00 201510dE800